IDARUCIZUMAB

1356 reported adverse events

Drug classes: Humanized Monoclonal Antibody Fragment [EPC]

These side effects are most commonly reported by patients taking IDARUCIZUMAB:

# Side effect Count
0 DEATH 163
1 HAEMORRHAGE 105
2 GASTROINTESTINAL HAEMORRHAGE 78
3 CEREBRAL HAEMORRHAGE 76
4 HAEMORRHAGE INTRACRANIAL 66
5 DRUG INEFFECTIVE 62
6 MULTIPLE ORGAN DYSFUNCTION SYNDROME 60
7 ACUTE KIDNEY INJURY 45
8 ISCHAEMIC STROKE 43
9 SEPSIS 43
See all common reactions for IDARUCIZUMAB

IDARUCIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 COAGULATION FACTOR INCREASED 5 0.0926
1 THROMBIN TIME ABNORMAL 3 0.0714
2 ANTICOAGULATION DRUG LEVEL INCREASED 11 0.0409
3 BASILAR ARTERY OCCLUSION 5 0.0336
4 THROMBIN TIME PROLONGED 6 0.0283
5 ANTICOAGULATION DRUG LEVEL ABNORMAL 2 0.0227
6 HAEMORRHAGIC TRANSFORMATION STROKE 26 0.0196
7 VERTEBRAL ARTERY OCCLUSION 3 0.0150
8 PULMONARY RENAL SYNDROME 3 0.0115
9 RECTAL PERFORATION 5 0.0108
See all enriched reactions for IDARUCIZUMAB